Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
43.33
+2.96 (7.33%)
At close: Jul 26, 2024, 4:00 PM
44.01
+0.68 (1.57%)
After-hours: Jul 26, 2024, 6:55 PM EDT
Mirum Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 224 | 186.37 | 77.06 | 19.14 | - | - | Upgrade
|
| Revenue Growth (YoY) | 133.90% | 141.85% | 302.66% | - | - | - | Upgrade
|
| Cost of Revenue | 59.89 | 47.04 | 12.37 | 1.9 | - | - | Upgrade
|
| Gross Profit | 164.11 | 139.34 | 64.69 | 17.24 | - | - | Upgrade
|
| Selling, General & Admin | 161.3 | 145.88 | 89.07 | 59.22 | 22.69 | 11.75 | Upgrade
|
| Research & Development | 111.28 | 102.61 | 106.84 | 131.43 | 81.61 | 42.99 | Upgrade
|
| Operating Expenses | 272.58 | 248.49 | 195.91 | 190.65 | 104.3 | 54.74 | Upgrade
|
| Operating Income | -108.47 | -109.15 | -131.22 | -173.41 | -104.3 | -54.74 | Upgrade
|
| Interest Expense | -14.44 | -15.11 | -15.98 | -17.59 | -0.34 | - | Upgrade
|
| Interest & Investment Income | 15.1 | 13.74 | 3.86 | 0.37 | 1.56 | 2.23 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.7 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -51.03 | -51.9 | 1.27 | 106.69 | -0.19 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -157.15 | -162.42 | -142.07 | -83.95 | -103.26 | -52.53 | Upgrade
|
| Pretax Income | -157.15 | -162.42 | -142.07 | -83.95 | -103.26 | -52.53 | Upgrade
|
| Income Tax Expense | 1.41 | 0.99 | -6.41 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Net Income | -158.56 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 | Upgrade
|
| Net Income to Common | -158.56 | -163.42 | -135.67 | -83.99 | -103.27 | -52.55 | Upgrade
|
| Shares Outstanding (Basic) | 43 | 41 | 34 | 30 | 25 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 41 | 34 | 30 | 25 | 11 | Upgrade
|
| Shares Change (YoY) | 21.91% | 20.31% | 12.07% | 20.08% | 119.84% | 1177.21% | Upgrade
|
| EPS (Basic) | -3.67 | -4.00 | -4.01 | -2.77 | -4.09 | -4.58 | Upgrade
|
| EPS (Diluted) | -3.67 | -4.00 | -4.02 | -2.77 | -4.09 | -4.58 | Upgrade
|
| Free Cash Flow | -37.04 | -71.05 | -120.41 | -132.78 | -89.3 | -39.64 | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -1.74 | -3.54 | -4.38 | -3.54 | -3.45 | Upgrade
|
| Gross Margin | 73.26% | 74.76% | 83.94% | 90.06% | - | - | Upgrade
|
| Operating Margin | -48.43% | -58.57% | -170.28% | -906.12% | - | - | Upgrade
|
| Profit Margin | -70.79% | -87.68% | -176.05% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -16.54% | -38.12% | -156.26% | -693.81% | - | - | Upgrade
|
| EBITDA | -93.32 | -98.33 | -127.98 | -172.82 | -103.99 | -54.6 | Upgrade
|
| EBITDA Margin | -41.66% | -52.76% | -166.08% | - | - | - | Upgrade
|
| D&A For EBITDA | 15.16 | 10.83 | 3.24 | 0.6 | 0.31 | 0.14 | Upgrade
|
| EBIT | -108.47 | -109.15 | -131.22 | -173.41 | -104.3 | -54.74 | Upgrade
|
| EBIT Margin | -48.43% | -58.57% | -170.28% | - | - | - | Upgrade
|
| Revenue as Reported | 224 | 186.37 | 77.06 | 19.14 | - | - | Upgrade
|
| Advertising Expenses | - | 6.3 | 4 | 9.2 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.